Obesity rates in the UK might start falling by the end of 2024 due to the rising use of weight loss medications like Wegovy and Mounjaro, according to Simple Online Pharmacy, Sky News reports.

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

Doctors have long told how they are treating increasing numbers of Brits who end up in hospital after providing false ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, ...

KERRY Katona has shared one of the heartbreaking reasons that is behind her recent drastic weight loss. The mum-of-five has ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

I pray that my kids never struggle with their body images enough to mutilate their bodies to be skinny,” the “Teen Mom 2” ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...